Actualités Grupo Aeroportuario del Centro Norte SAB de CV - OMAB | Actions NASDAQ

Outset Medical to Present at the BofA Securities 2022 Healthcare Conference

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K ...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K &nbs...

Outset Medical Names Business Leader Dale E. Jones to Board of Directors

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of dialysis, today announced the...

Outset Medical to Report First Quarter 2022 Financial Results on Wednesday, May 4, 2022

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Outset Medical Presents New Data on Home Dialysis at National Kidney Foundation Spring Meetings

Findings Show Tablo® Hemodialysis System Increases Patient and Physician Likelihood to Adopt Home Hemodialysis (HHD) Today, Outset Medical, Inc...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF...

Outset Medical to Present at 42nd Annual Cowen Health Care Conference

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and...

Outset Medical Reports Fourth Quarter and Full Year 2021 Financial Results

Record Annual Revenue of $102.6 Million; 105% Year-over-Year Growth Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical...

Outset Medical to Present at SVB Leerink Global Healthcare Conference

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and...

Outset Medical to Report Fourth Quarter and Full Year 2021 Financial Results on Wednesday, February 16, 2022

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Grupo Aeroportuario del Centro Norte SAB de CV (OMAB)

Votre Hub pour des idées et discussions en direct en temps réel

OMAB Actualités

Outset Medical to Present at the BofA Securities 2022 Healthcare Conference

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Outset Medical Names Business Leader Dale E. Jones to Board of Directors

Outset Medical to Report First Quarter 2022 Financial Results on Wednesday, May 4, 2022

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Outset Medical Presents New Data on Home Dialysis at National Kidney Foundation Spring Meetings

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Outset Medical to Present at 42nd Annual Cowen Health Care Conference

Outset Medical Reports Fourth Quarter and Full Year 2021 Financial Results

Outset Medical to Present at SVB Leerink Global Healthcare Conference

Outset Medical to Report Fourth Quarter and Full Year 2021 Financial Results on Wednesday, February 16, 2022

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Grupo Aeroportuario del Centro Norte SAB de CV (OMAB) Actualités

Grupo Aeroportuario del Centro Norte SAB de CV (OMAB)

Votre Hub pour des idées et discussions en direct en temps réel

OMAB Actualités

Outset Medical to Present at the BofA Securities 2022 Healthcare Conference

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Outset Medical Names Business Leader Dale E. Jones to Board of Directors

Outset Medical to Report First Quarter 2022 Financial Results on Wednesday, May 4, 2022

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Outset Medical Presents New Data on Home Dialysis at National Kidney Foundation Spring Meetings

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Outset Medical to Present at 42nd Annual Cowen Health Care Conference

Outset Medical Reports Fourth Quarter and Full Year 2021 Financial Results

Outset Medical to Present at SVB Leerink Global Healthcare Conference

Outset Medical to Report Fourth Quarter and Full Year 2021 Financial Results on Wednesday, February 16, 2022

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités